AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min chapter
Episode 20. Management of Myeloma in LMICs
Blood Cancer Talks
The Importance of Monitoring Myeloma Markers
After transplant, in myeloma, unfortunately, we cannot give them a treatment-free remission. So basically everybody is on revlimate at least for two to three years. And after that, if there has been two consequent MRD negative, then I discuss with the patient that to hold the limit and watch closely the myeloma markers. Although there is no randomized trial showing that approach is perfectly safe, but there are some single-arm trials now that's coming out.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode